CBT Add to watchlist $87.51 0.20 (-0.23%) Last updated: May 31, 2026 06:44
52-Week Range
$87.51
$58.33 $87.51 $89.46

Fundamentals Overview

Cabot Corporation is near the high of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 16 P/B 2.9 P/S 1.26

Intrinsic value (DCF)

+64.9% upside vs price

Profitability

Net margin 8%

Risk (Beta)

0.78 — lower vol

Earnings & growth

EPS $5.46 Rev +6.5% Profit -6.8% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Buy — 70% confidence Risk: Lower Volatility — Beta 0.78. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +64.9% upside vs price · Analyst grade: A- · 3M vs S&P 500: +6.2% · 3M vs Basic Materials sector: +18.9%

Pressures (Sell):

Sentiment weakening (5 downgrades)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$4.52B
P/E (TTM)
16.03
EPS (TTM)
$5.46
Dividend Yield
2.08%
52-Week Range
$58.33 - $89.46
Volume vs Avg
N/A
Beta
0.78

About

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, pl...
Sector: Basic Materials
Headquarters: US
Employees: 4,151
IPO Date: Nov 1980
Beta: 0.78 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 5, Hold: 1, Neutral: 14, Outperform: 6, Underweight: 4.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $144.27; current price is $87.51. That’s a +64.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 16.03
DCF value (model) $144.27 (64.9% upside)
PEG (TTM) N/A
P/B (TTM) 2.9
P/S (TTM) 1.26
P/FCF (TTM) 9.84
Liquidity & enterprise
Current Ratio (TTM) 1.45
Quick Ratio (TTM) 0.96
Cash Ratio (TTM) 0.24
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 7.97%
Gross margin (TTM) 24.95%
Operating margin (TTM) 15.94%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CBT.

Analyst Sentiment at a Glance

A- Sentiment Weakening
Buy 5Hold 1Neutral 14Outperform 6Underweight 4
0 upgrades, 5 downgrades
Price Target Consensus
Current $87.51
Median $85.00
Consensus $82.00
Low consensus $75.00
High consensus $86.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
JP Morgan maintain Underweight Underweight 2026-05-13
UBS maintain Neutral Neutral 2026-05-08
Mizuho maintain Neutral Neutral 2026-05-06
UBS maintain Neutral Neutral 2026-02-05
Mizuho downgrade Outperform Neutral 2026-02-05
UBS maintain Neutral Neutral 2026-01-12
Mizuho maintain Outperform Outperform 2025-12-18
JP Morgan maintain Underweight Underweight 2025-11-28
Mizuho maintain Outperform Outperform 2025-11-17
UBS maintain Neutral Neutral 2025-11-05
Mizuho maintain Outperform Outperform 2025-10-03
UBS maintain Neutral Neutral 2025-08-05
UBS maintain Neutral Neutral 2025-04-07
JP Morgan maintain Underweight Underweight 2025-02-21
Mizuho maintain Outperform Outperform 2025-01-07
JP Morgan downgrade Neutral Underweight 2024-11-11
Mizuho maintain Outperform Outperform 2024-11-05
JP Morgan maintain Neutral Neutral 2024-08-07
UBS maintain Neutral Neutral 2024-08-06
UBS maintain Neutral Neutral 2024-05-07
Mizuho maintain Buy Buy 2024-05-07
Deutsche Bank downgrade Buy Hold 2024-04-18
UBS downgrade Buy Neutral 2024-01-08
UBS maintain Buy Buy 2023-12-14
UBS maintain Buy Buy 2023-11-07
JP Morgan maintain Neutral Neutral 2023-08-11
Credit Suisse maintain Outperform Outperform 2023-08-08
Loop Capital maintain Buy Buy 2023-06-20
JP Morgan downgrade Overweight Neutral 2023-06-06
Deutsche Bank maintain Buy Buy 2023-05-18